VOYA Investment Management
RIGL icon

VOYA Investment Management’s Rigel Pharmaceuticals RIGL Stock Holding History

VOYA Investment Management’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-43,399
Closed -$1.23M – 2465
2025
Q3 		$1.23M Sell
43,399
-49,278
-53% -$1.47M ﹤0.01% 1411
2025
Q2 		$1.74M Buy
92,677
+6,501
+8% +$123K ﹤0.01% 1359
2025
Q1 		$1.55M Sell
86,176
-22,411
-21% -$455K ﹤0.01% 1404
2024
Q4 		$1.83M Sell
108,587
-132,381
-55% -$2.54M ﹤0.01% 1340
2024
Q3 		$3.9M Buy
240,968
+122,090
+103% +$1.44M ﹤0.01% 1100
2024
Q2 		$977K Sell
118,878
-62,509
-34% -$654K ﹤0.01% 1641
2024
Q1 		$2.68M Sell
181,387
-27,915
-13% -$376K ﹤0.01% 1240
2023
Q4 		$3.03M Buy
209,302
+3,592
+2% +$36.7K ﹤0.01% 1196
2023
Q3 		$2.22M Buy
205,710
+115,726
+129% +$1.39M ﹤0.01% 1292
2023
Q2 		$1.16M Sell
89,984
-44,839
-33% -$606K ﹤0.01% 1581
2023
Q1 		$1.78M Sell
134,823
-165,026
-55% -$2.62M ﹤0.01% 1402
2022
Q4 		$4.5M Sell
299,849
-59,910
-17% -$549K 0.01% 1017
2022
Q3 		$4.25M Buy
359,759
+348,504
+3,096% +$4.71M 0.01% 1019
2022
Q2 		$128K Buy
11,255
+3,822
+51% +$76.8K ﹤0.01% 2557
2022
Q1 		$222K Buy
7,433
+667
+10% +$18.1K ﹤0.01% 2316
2021
Q4 		$179K Sell
6,766
-256
-4% -$7.72K ﹤0.01% 2549
2021
Q3 		$254K Buy
7,022
+69
+1% +$2.72K ﹤0.01% 2437
2021
Q2 		$302K Sell
6,953
-787
-10% -$29.7K ﹤0.01% 2374
2021
Q1 		$265K Buy
7,740
+321
+4% +$12.7K ﹤0.01% 2383
2020
Q4 		$260K Buy
7,419
+1,160
+19% +$33.6K ﹤0.01% 2276
2020
Q3 		$150K Hold
6,259
– – ﹤0.01% 2246
2020
Q2 		$115K Sell
6,259
-2,297
-27% -$41.3K ﹤0.01% 2311
2020
Q1 		$133K Hold
8,556
– – ﹤0.01% 2268
2019
Q4 		$183K Buy
8,556
+1,058
+14% +$21.8K ﹤0.01% 2405
2019
Q3 		$140K Hold
7,498
– – ﹤0.01% 2328
2019
Q2 		$196K Buy
7,498
+631
+9% +$14.2K ﹤0.01% 2310
2019
Q1 		$176K Hold
6,867
– – ﹤0.01% 2309
2018
Q4 		$158K Hold
6,867
– – ﹤0.01% 2289
2018
Q3 		$220K Hold
6,867
– – ﹤0.01% 2292
2018
Q2 		$194K Buy
6,867
+425
+7% +$15.1K ﹤0.01% 2368
2018
Q1 		$228K Hold
6,442
– – ﹤0.01% 2254
2017
Q4 		$250K Buy
6,442
+1,076
+20% +$41K ﹤0.01% 2239
2017
Q3 		$136K Hold
5,366
– – ﹤0.01% 2484
2017
Q2 		$146K Buy
5,366
+1,250
+30% +$34.2K ﹤0.01% 2488
2017
Q1 		$136K Hold
4,116
– – ﹤0.01% 2383
2016
Q4 		$98K Hold
4,116
– – ﹤0.01% 2457
2016
Q3 		$151 Hold
4,116
– – ﹤0.01% 2392
2016
Q2 		$92K Hold
4,116
– – ﹤0.01% 2484
2016
Q1 		$86K Hold
4,116
– – ﹤0.01% 2427
2015
Q4 		$125K Hold
4,116
– – ﹤0.01% 2432
2015
Q3 		$102K Sell
4,116
-1,785
-30% -$53.3K ﹤0.01% 2484
2015
Q2 		$189K Sell
5,901
-882
-13% -$33.7K ﹤0.01% 2500
2015
Q1 		$242K Sell
6,783
-2,672
-28% -$73.3K ﹤0.01% 2360
2014
Q4 		$215K Sell
9,455
-2
-0% -$40 ﹤0.01% 2445
2014
Q3 		$183K Hold
9,457
– – ﹤0.01% 2510
2014
Q2 		$343K Hold
9,457
– – ﹤0.01% 2263
2014
Q1 		$367K Hold
9,457
– – ﹤0.01% 2202
2013
Q4 		$270K Hold
9,457
– – ﹤0.01% 2369
2013
Q3 		$339K Hold
9,457
– – ﹤0.01% 2206
2013
Q2 		$316K Buy
+9,457
New +$429K ﹤0.01% 2205

Other funds holding RIGL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

VOYA Investment Management's RIGL Position: Q4 2025 in Review

VOYA Investment Management sold out of Rigel Pharmaceuticals (RIGL) in Q4 2025, closing a stake of 43,399 shares — an estimated $1.23M sold.

VOYA Investment Management first reported a position in RIGL in Q2 2013 and held it in 50 quarters. The position peaked at $4.5M in Q4 2022. 193 funds tracked by Wall St. Rank hold RIGL as of Q4 2025.

  • VOYA Investment Management reported no remaining Rigel Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • VOYA Investment Management sold 43,399 Rigel Pharmaceuticals shares in Q4 2025, an estimated $1.23M.
  • VOYA Investment Management first reported a position in Rigel Pharmaceuticals in Q2 2013 and held it in 50 quarters.
  • VOYA Investment Management's Rigel Pharmaceuticals position peaked at $4.5M in Q4 2022.
  • 193 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q4 2025.

Based on VOYA Investment Management's 13F filing for Q4 2025, filed 12 Feb 2026.